It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

Pax Genes in Adult Primary Brain Tumor Study

Clinical Trial Title: 
Identification and Modification of Pax Genes in Adult Primary Brain Tumors
Clinical Trial Protocol ID: 
10012903
Clinical Trial Investigator Name: 
Richard Byrne, MD
Clinical Trial Protocol Description: 

Patients who are candidates for brain surgery during which brain tumor tissue will be taken out as part of the standard surgical procedure are invited to donate a portion of this tissue and medical information about themselves in order to allow physicians to study brain tumors. The purpose of this study is to determine the activity and effects of two specific genes in brain tumors. These genes may be involved in the growth of brain tumors. Once identified from the tissue of brain tumors, their activity will be stopped along with growth of the tumor sample. The results from this study will provide valuable information on the role of these specific genes in brain tumors.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are having brain surgery as part of medical management of a primary brain tumor

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Brain Tumors
Contact Phone: 
(312) 942-8614
Contact Name: 
Michelle Smreczak